A survey of patients with facial angiofibromas associated with tuberous sclerosis complex: Short-, medium- and long-term efficacy and safety of topical rapamycin-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

A survey of patients with facial angiofibromas associated with tuberous sclerosis complex: Short-, medium- and long-term efficacy and safety of topical rapamycin

Published:2023-12 Issue:4 Volume:150 Page:270-273
ISSN:0151-9638
Container-title:Annales de Dermatologie et de Vénéréologie
language:en
Short-container-title:Annales de Dermatologie et de Vénéréologie

Author:

Sigg N.,Fouquet J.,Morin D.,Farges D.,Vrignaud S.,Martin L.

Publisher

Elsevier BV

Subject

Dermatology

Reference24 articles.

1. Tuberous sclerosis complex: genetics to pathogenesis;Narayanan;Pediatr Neurol,2003

2. International tuberous sclerosis complex consensus group. Tuberous sclerosis complex diagnostic criteria update: recommendations of the international tuberous sclerosis complex consensus conference;Northrup;Pediatr Neurol,2012

3. Carbon dioxide and pulsed dye laser treatment of angiofibromas in 29 patients with tuberous sclerosis;Papadavid;Br J Dermatol,2002

4. Sirolimus (rapamycin): from the soil of Easter Island to a bright future;Paghdal;J Am Acad Dermatol,2007

5. Long-term use of everolimus in patients with tuberous sclerosis complex: Final results from the EXIST-1 study;Franz;PLoS One,2016

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP